CES 2025: MIFA Yukon– Outdoor Bluetooth speaker with Low-Latency intercoms
NEWARK, Del., Jan. 9, 2025 /PRNewswire/ — MIFA is a leading innovator in the audio industry field and the latest…
Media Advisory – Prime Minister’s itinerary for Friday, January 10, 2025
OTTAWA, ON, Jan. 9, 2025 /CNW/ – Washington, D.C., United States of America The Prime Minister will depart for Ottawa,…
ICAHN ENTERPRISES L.P. AND ICAHN ENTERPRISES HOLDINGS L.P. ANNOUNCE RESULTS OF TENDER OFFER FOR UP TO 17,753,322 SHARES OF COMMON STOCK OF CVR ENERGY
SUNNY ISLES BEACH, Fla., Jan. 9, 2025 /PRNewswire/ — Icahn Enterprises L.P. (NASDAQ: IEP) (“IEP”) and Icahn Enterprises Holdings L.P.…
RTO Investors Have Opportunity to Lead Rentokil Initial plc Securities Fraud Lawsuit
NEW YORK, Jan. 9, 2025 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of…
Global Technology Industry Association (GTIA) debuts new name, singular focus on IT channel
GTIA, formerly known as the CompTIA Community, will continue to serve MSP/solution provider, tech vendor, distributor and other members as…
After-School Tutoring Market in China to grow by USD 130.8 Billion (2025-2029), outcome-based education driving growth, AI powering market transformation – Technavio
NEW YORK, Jan. 9, 2025 /PRNewswire/ — Report with the AI impact on market trends – The after-school tutoring market…
Aleut Achieves Prestigious CMMI Level 3 Certification in Four Key Domains
RESTON, Va., Jan. 9, 2025 /PRNewswire/ — Aleut Federal LLC (Aleut) proudly announces it has earned Capability Maturity Model Integration…
BARDA and Partner Therapeutics continue partnership around development of LEUKINE® (sargramostim, rhu GM-CSF) to potentially improve patient care for sepsis
LEXINGTON, Mass., Jan. 9, 2025 /PRNewswire/ — Partner Therapeutics, Inc. (PTx) today announced a collaboration with the Biomedical Advanced Research…
TUMS Teams Up with DraftKings to Launch TUMS Fantasy Foodball Pool, Making Gameday Food Dreams a Reality
Fans can draft their top food and drink picks for a free shot at winning a share of $40,000 in total…
Mabwell’s Nectin-4 Targeted ADC 9MW2821 Combination Therapy Demonstrates 87.5% ORR and Granted CDE Breakthrough Therapy Designation
SHANGHAI, Jan. 9, 2025 /PRNewswire/ — Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced a significant milestone…
↑